Stool Softener Market Industry Outlook 2026–2030 Highlighting Growth Momentum And Market Trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Stool Softener Market Compare Between 2026 And 2030?

The stool softener market has experienced significant expansion in recent years. Its valuation is projected to increase from $1.81 billion in 2025 to $1.94 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. The historical drivers for this growth include the high prevalence of chronic constipation, an aging demographic, the rise in opioid-induced constipation cases, improved over-the-counter availability, and established physician prescribing habits.

The stool softener market is anticipated to experience substantial growth over the upcoming years. Its valuation is projected to reach $2.51 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.6%. This expansion during the forecast period is attributable to factors such as an escalating geriatric population, the growth of home healthcare services, a rising demand for gentle laxatives, increased public awareness regarding digestive health, and the expansion of retail pharmacy networks. Prominent trends expected in this period include the development of plant-based formulations, sugar-free laxative options, flavored oral dosage forms, combination stool softeners, and products suitable for pediatric use.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16548&type=smp

Which Growth Factors Are Strengthening The Stool Softener Market Landscape?

The increasing prevalence of gastrointestinal disorders is anticipated to propel the growth of the stool softener market going forward. These disorders refer to any condition or disease affecting the gastrointestinal tract, which comprises the mouth, esophagus, stomach, small intestine, large intestine, and anus. The rising incidence of gastrointestinal disorders is linked to various factors, including lifestyle changes like poor diet, insufficient exercise, and stress. Stool softeners aid in alleviating gastrointestinal disorders by making stools easier to pass, thereby preventing constipation and reducing strain during bowel movements. For instance, in 2023, according to Crohn’s and Colitis Canada, a Canada-based non-profit organization, the number of people in Canada with IBD is increasing rapidly, from 322,600 in 2023 (0.8% of the population) to 470,000 in 2035 (1.1% of the population). In 2023, 11,000 people will be diagnosed (1 every 48 minutes), and by 2035, this will rise to 14,000 (1 every 38 minutes). Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the stool softener market.

Which Segment Divisions Form The Structure Of The Stool Softener Market?

The stool softener market covered in this report is segmented –

1) By Type: Liquid, Softgel Capsule

2) By Form: Medicines, Prescription Products

3) By Mode Of Administration: Oral, Rectal

4) By Availability: Over-The-Counter, Prescription

5) By End Use: Hospitals, Clinics, Home Care, Other End Uses

Subsegments:

1) By Liquid: Oral Solutions, Syrups, Drops

2) By Softgel Capsule: Standard Softgel Capsules, Enhanced Or High-Dosage Softgel Capsules

Which Trends Are Influencing The Expansion Of The Stool Softener Market?

Leading companies within the stomach cancer treatment market are concentrating on developing advanced solutions, such as claudin (CLDN18.2)-targeted cytolytic antibody therapy, to boost precision in first-line treatments for HER2-negative gastric and gastroesophageal junction (GEJ) adenocarcinoma. Claudin (CLDN18.2)-targeted cytolytic antibody therapy employs a monoclonal antibody designed to selectively attach to CLDN18.2-expressing tumor cells and induce cytotoxic effects when combined with chemotherapy, thereby enhancing both progression-free and overall survival outcomes. For example, in October 2024, Astellas Pharma US, Inc., a Japan-based pharmaceutical company, introduced Vyloy (zolbetuximab-clzb), a claudin (CLDN18.2)-directed cytolytic antibody for the treatment of gastric and gastroesophageal junction (GEJ) cancer. This innovative biologic therapy is administered intravenously alongside fluoropyrimidine- and platinum-containing chemotherapy, demonstrating a median progression-free survival benefit of up to 10.6 months and overall survival of up to 18.2 months in clinical trials. The therapy specifically targets CLDN18.2-positive cancer cells, minimizing off-target toxicity and increasing treatment specificity, marking a significant advancement in personalized oncology for advanced gastric cancer.

Who Are The Businesses Driving Activity In The Stool Softener Market?

Major companies operating in the stool softener market are F. Hoffmann-La Roche Ltd., Bayer AG, AstraZeneca Plc., Abbott Laboratories Inc., Takeda Pharmaceutical Company Ltd., GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Solvay S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Purdue Pharma L.P., Mallinckrodt Plc, Aristo Pharma GmbH, Raptakos Brett Co. Ltd., Unipex Group Inc., Chemo Biological, Angiolife Healthcare Pvt. Ltd., Iscon Life Sciences, Starmed Pvt. Ltd., Phaedrus Ltd., Stadmed Pvt. Ltd., Avrio Health L.P., Healwell, Velnex Medicare, Sanify Healthcare Pvt. Ltd.

Access The Complete Stool Softener Market Report:

https://www.thebusinessresearchcompany.com/report/stool-softener-global-market-report

Which Region Commands The Largest Share Of The Stool Softener Market?

North America was the largest region in the stool softener market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stool softener market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Stool Softener Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16548&type=smp

Browse Through More Reports Similar to the Global Stool Softener Market 2026, By The Business Research Company

Gastrointestinal Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

Constipation Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Soft Drinks Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/soft-drinks-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795